Loading…

Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography

•Simultaneous determination of 9 potentially genotoxic aromatic amine impurities.•Method controls all genotoxic impurities in the entire synthetic route of Crotamiton.•40 ppm specification limit was needed for each impurity.•Method development without mass spectrometer detection or analyte preconcen...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical and biomedical analysis 2022-02, Vol.210, p.114544-114544, Article 114544
Main Authors: Kalauz, Andrea, Kapui, Imre
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713
cites cdi_FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713
container_end_page 114544
container_issue
container_start_page 114544
container_title Journal of pharmaceutical and biomedical analysis
container_volume 210
creator Kalauz, Andrea
Kapui, Imre
description •Simultaneous determination of 9 potentially genotoxic aromatic amine impurities.•Method controls all genotoxic impurities in the entire synthetic route of Crotamiton.•40 ppm specification limit was needed for each impurity.•Method development without mass spectrometer detection or analyte preconcentration.•Fully validated and the applicability was tested in several samples. In the recent years control of potentially genotoxic impurities have an increasing importance in the analysis of active pharmaceutical ingredients. Guidelines of different regulatory bodies specify very low limits for these impurities, in many cases the analytical development is challenging to comply with the requirements. In this paper potential genotoxic impurities of Crotamiton drug substance are investigated, a simple and robust gas chromatographic method is developed for the determination of genotoxic impurities in Crotamiton drug substance. One of the main benefits of this method is that it can quantify all potential genotoxic impurities that can be present in the entire synthesis pathway of Crotamiton drug substance. Crotamiton is synthesized from toluidine derivatives, in which the aromatic amine group represents genotoxic alert. In the method development toluidine isomers (o-, m-, p-toluidine), N-ethyl-toluidine isomers (o-, m-, N-ethyl-p-toluidine) and N-methyl-toluidine isomers (o-, m-, N-methyl-p-toluidine) were separated, and the developed gas chromatographic method is validated in accordance with the relevant guidelines at a specification limit of NMT 40 ppm.
doi_str_mv 10.1016/j.jpba.2021.114544
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2615918535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708521006555</els_id><sourcerecordid>2615918535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713</originalsourceid><addsrcrecordid>eNp9kM1q3DAURkVpaKZpX6CLomU3nurKkmxDNyXpHwSySaE7IUvXMxpsy5XkIfP21TBpl10JwfkO3EPIO2BbYKA-HraHpTdbzjhsAYQU4gXZQNvUFVfi10uyYU0NVcNaeU1ep3RgjEnoxCtyXYtOtV3XbMjxDjPGyc8m-zDTMNAlZJyzN-N4ojucQw5P3lI_LWv02WOifqY2hmwmn8vC2OyPSJe9iZOxuGZvzViYXUTni4j2RWMStfsYJpPDLpplf3pDrgYzJnz7_N6Qn1-_PN5-r-4fvv24_Xxf2VqqXHEA5xrJahz6GvngjDCucX2jLPQcrGwFCM5aYXsFg22VVK6vXVf-3LEG6hvy4eJdYvi9Ysp68sniOJoZw5o0VyA7aGUtC8ovaDkupYiDXqKfTDxpYPrcWx_0ubc-99aX3mX0_tm_9hO6f5O_gQvw6QJgufLoMepkSxZb4kS0Wbvg_-f_A_SMlPU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2615918535</pqid></control><display><type>article</type><title>Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography</title><source>ScienceDirect Journals</source><creator>Kalauz, Andrea ; Kapui, Imre</creator><creatorcontrib>Kalauz, Andrea ; Kapui, Imre</creatorcontrib><description>•Simultaneous determination of 9 potentially genotoxic aromatic amine impurities.•Method controls all genotoxic impurities in the entire synthetic route of Crotamiton.•40 ppm specification limit was needed for each impurity.•Method development without mass spectrometer detection or analyte preconcentration.•Fully validated and the applicability was tested in several samples. In the recent years control of potentially genotoxic impurities have an increasing importance in the analysis of active pharmaceutical ingredients. Guidelines of different regulatory bodies specify very low limits for these impurities, in many cases the analytical development is challenging to comply with the requirements. In this paper potential genotoxic impurities of Crotamiton drug substance are investigated, a simple and robust gas chromatographic method is developed for the determination of genotoxic impurities in Crotamiton drug substance. One of the main benefits of this method is that it can quantify all potential genotoxic impurities that can be present in the entire synthesis pathway of Crotamiton drug substance. Crotamiton is synthesized from toluidine derivatives, in which the aromatic amine group represents genotoxic alert. In the method development toluidine isomers (o-, m-, p-toluidine), N-ethyl-toluidine isomers (o-, m-, N-ethyl-p-toluidine) and N-methyl-toluidine isomers (o-, m-, N-methyl-p-toluidine) were separated, and the developed gas chromatographic method is validated in accordance with the relevant guidelines at a specification limit of NMT 40 ppm.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/j.jpba.2021.114544</identifier><identifier>PMID: 34968997</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Aromatic amines ; Chromatography, Gas ; Chromatography, High Pressure Liquid ; Crotamiton ; DNA Damage ; Drug Contamination ; Gas chromatography ; Genotoxic/mutagenic impurities ; Pharmaceutical Preparations ; Toluidines ; Validation</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 2022-02, Vol.210, p.114544-114544, Article 114544</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713</citedby><cites>FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34968997$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kalauz, Andrea</creatorcontrib><creatorcontrib>Kapui, Imre</creatorcontrib><title>Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>•Simultaneous determination of 9 potentially genotoxic aromatic amine impurities.•Method controls all genotoxic impurities in the entire synthetic route of Crotamiton.•40 ppm specification limit was needed for each impurity.•Method development without mass spectrometer detection or analyte preconcentration.•Fully validated and the applicability was tested in several samples. In the recent years control of potentially genotoxic impurities have an increasing importance in the analysis of active pharmaceutical ingredients. Guidelines of different regulatory bodies specify very low limits for these impurities, in many cases the analytical development is challenging to comply with the requirements. In this paper potential genotoxic impurities of Crotamiton drug substance are investigated, a simple and robust gas chromatographic method is developed for the determination of genotoxic impurities in Crotamiton drug substance. One of the main benefits of this method is that it can quantify all potential genotoxic impurities that can be present in the entire synthesis pathway of Crotamiton drug substance. Crotamiton is synthesized from toluidine derivatives, in which the aromatic amine group represents genotoxic alert. In the method development toluidine isomers (o-, m-, p-toluidine), N-ethyl-toluidine isomers (o-, m-, N-ethyl-p-toluidine) and N-methyl-toluidine isomers (o-, m-, N-methyl-p-toluidine) were separated, and the developed gas chromatographic method is validated in accordance with the relevant guidelines at a specification limit of NMT 40 ppm.</description><subject>Aromatic amines</subject><subject>Chromatography, Gas</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Crotamiton</subject><subject>DNA Damage</subject><subject>Drug Contamination</subject><subject>Gas chromatography</subject><subject>Genotoxic/mutagenic impurities</subject><subject>Pharmaceutical Preparations</subject><subject>Toluidines</subject><subject>Validation</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kM1q3DAURkVpaKZpX6CLomU3nurKkmxDNyXpHwSySaE7IUvXMxpsy5XkIfP21TBpl10JwfkO3EPIO2BbYKA-HraHpTdbzjhsAYQU4gXZQNvUFVfi10uyYU0NVcNaeU1ep3RgjEnoxCtyXYtOtV3XbMjxDjPGyc8m-zDTMNAlZJyzN-N4ojucQw5P3lI_LWv02WOifqY2hmwmn8vC2OyPSJe9iZOxuGZvzViYXUTni4j2RWMStfsYJpPDLpplf3pDrgYzJnz7_N6Qn1-_PN5-r-4fvv24_Xxf2VqqXHEA5xrJahz6GvngjDCucX2jLPQcrGwFCM5aYXsFg22VVK6vXVf-3LEG6hvy4eJdYvi9Ysp68sniOJoZw5o0VyA7aGUtC8ovaDkupYiDXqKfTDxpYPrcWx_0ubc-99aX3mX0_tm_9hO6f5O_gQvw6QJgufLoMepkSxZb4kS0Wbvg_-f_A_SMlPU</recordid><startdate>20220220</startdate><enddate>20220220</enddate><creator>Kalauz, Andrea</creator><creator>Kapui, Imre</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220220</creationdate><title>Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography</title><author>Kalauz, Andrea ; Kapui, Imre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aromatic amines</topic><topic>Chromatography, Gas</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Crotamiton</topic><topic>DNA Damage</topic><topic>Drug Contamination</topic><topic>Gas chromatography</topic><topic>Genotoxic/mutagenic impurities</topic><topic>Pharmaceutical Preparations</topic><topic>Toluidines</topic><topic>Validation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kalauz, Andrea</creatorcontrib><creatorcontrib>Kapui, Imre</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kalauz, Andrea</au><au>Kapui, Imre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>2022-02-20</date><risdate>2022</risdate><volume>210</volume><spage>114544</spage><epage>114544</epage><pages>114544-114544</pages><artnum>114544</artnum><issn>0731-7085</issn><eissn>1873-264X</eissn><abstract>•Simultaneous determination of 9 potentially genotoxic aromatic amine impurities.•Method controls all genotoxic impurities in the entire synthetic route of Crotamiton.•40 ppm specification limit was needed for each impurity.•Method development without mass spectrometer detection or analyte preconcentration.•Fully validated and the applicability was tested in several samples. In the recent years control of potentially genotoxic impurities have an increasing importance in the analysis of active pharmaceutical ingredients. Guidelines of different regulatory bodies specify very low limits for these impurities, in many cases the analytical development is challenging to comply with the requirements. In this paper potential genotoxic impurities of Crotamiton drug substance are investigated, a simple and robust gas chromatographic method is developed for the determination of genotoxic impurities in Crotamiton drug substance. One of the main benefits of this method is that it can quantify all potential genotoxic impurities that can be present in the entire synthesis pathway of Crotamiton drug substance. Crotamiton is synthesized from toluidine derivatives, in which the aromatic amine group represents genotoxic alert. In the method development toluidine isomers (o-, m-, p-toluidine), N-ethyl-toluidine isomers (o-, m-, N-ethyl-p-toluidine) and N-methyl-toluidine isomers (o-, m-, N-methyl-p-toluidine) were separated, and the developed gas chromatographic method is validated in accordance with the relevant guidelines at a specification limit of NMT 40 ppm.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>34968997</pmid><doi>10.1016/j.jpba.2021.114544</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0731-7085
ispartof Journal of pharmaceutical and biomedical analysis, 2022-02, Vol.210, p.114544-114544, Article 114544
issn 0731-7085
1873-264X
language eng
recordid cdi_proquest_miscellaneous_2615918535
source ScienceDirect Journals
subjects Aromatic amines
Chromatography, Gas
Chromatography, High Pressure Liquid
Crotamiton
DNA Damage
Drug Contamination
Gas chromatography
Genotoxic/mutagenic impurities
Pharmaceutical Preparations
Toluidines
Validation
title Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T09%3A25%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determination%20of%20potentially%20genotoxic%20impurities%20in%20crotamiton%20active%20pharmaceutical%20ingredient%20by%20gas%20chromatography&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Kalauz,%20Andrea&rft.date=2022-02-20&rft.volume=210&rft.spage=114544&rft.epage=114544&rft.pages=114544-114544&rft.artnum=114544&rft.issn=0731-7085&rft.eissn=1873-264X&rft_id=info:doi/10.1016/j.jpba.2021.114544&rft_dat=%3Cproquest_cross%3E2615918535%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-211dd7503efb3e2fda4ad7db76c1b21c584142084cb61fc8656db3d94cb2d0713%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2615918535&rft_id=info:pmid/34968997&rfr_iscdi=true